Video summary

증시는 흔들려도, 기업은 커진다 | 이익도 늘고 투자도 늘어난 '산업확장 30선'

Main summary

Key takeaways

Finance

Finance-focused Summary (Industries / “Top 30 industrial expansion” screen)

Core idea / investment framing

  • The video argues that even when stock markets are volatile, companies in “industrial expansion” phases can grow profit and tangible assets, which may translate into future profit potential.
  • It emphasizes earnings-based corporate value, focusing on operating performance rather than short-term price moves.

Methodology / selection framework

From a broad universe of companies, the presenter selects Top 30 “industrial expansion” companies using the criteria:

  • Companies that grew both operating profit and tangible assets.

Then, the screen is further filtered into two highlight groups:

  • Top 10 by the improvement in operating profit margin (YoY) among the 30.
  • Top 10 by YoY growth rate in tangible assets among the 30.

Additional note:

  • The presenter also left brief comments on companies whose loan assets increased, reasoning that this can reflect expansion financing similar to how operating profit is supported.

Macro / market context mentioned

  • AI infrastructure investment is driving demand and capex across companies (example: Alphabet).
  • The presenter warns that heavy capital expenditures (capex) can increase short-term stock price volatility, even if the long-term goal is higher future profits.

Key examples and numbers

Alphabet (Google operator) — short-term free cash flow pressure from AI capex

  • Source event: “second-quarter 2026 earnings” (as stated in the subtitles).
  • Observed outcomes:
    • Revenue and operating profit increased
    • Free cash flow was negative/at a deficit, explained by:
      • large-scale facility investments focused on AI infrastructure
    • The stock price fell the day after the earnings announcement
  • Interpretation: capex-driven volatility is framed as future-profit investment.

“Top 10” by YoY improvement in operating profit margin (percentage-point gains)

  1. Samsung Electronics: +28.1 pp
  2. SK Hynix: +19.3 pp
  3. Sunik Systems: +15.7 pp
  4. SK Biopharmaceuticals: +14.6 pp
  5. RFHIC: +13.7 pp
  6. Konai: +13.2 pp
  7. SEM CNS: +13.0 pp
  8. Pharmicel: +12.9 pp
  9. EO Technics: +11.4 pp
  10. HD Hyundai Energy Solution: +7.0 pp

“Top 10” by YoY growth rate in tangible assets (percent increases)

  1. Hansun Engineering: +92.8%
  2. Sunik Systems: +65.6%
  3. HD Hyundai Marine Engine: +55.4%
  4. Celltrion: +38.2%
  5. TLB: +34.4%
  6. SK Hynix: +29.8%
  7. TFE: +22.5%
  8. KC Tech: +21.1%
  9. Protec: +19.9%
  10. Jusham: +9%

Company-specific “brief comments” (earnings + assets + investment plans)

SK Hynix (DRAM/NAND memory)

  • Business focus: DRAM and NAND flash
  • Operating profit margin:
    • Q1 (annualized) operating profit margin: 58.6%
    • +19.3 pp YoY (matches the earlier margin-improvement list)
  • Key driver cited: rise in memory prices, driven by server memory and enterprise SSDs
  • Tangible assets / investment:
    • acquired 7.3478 trillion won in new tangible assets in Q1 (this year) to meet AI-infrastructure-driven demand
    • plans to invest 19 trillion won in building PNT7 dedicated to advanced packaging

HD Hyundai Marine Engine (engine components)

  • Products cited: three-way low-speed engines, turbocharger crankshafts
  • Operating profit margin:
    • Q1 (annualized) operating profit margin: 21.7%
    • up from 10.7% in the same period last year (≈ +7 pp, as stated)
  • Drivers cited:
    • increase in average sales and operating rates
    • increased demand for ship engine crankshafts
  • Capex/investment:
    • plans to invest 68.4 billion won in marine engine crankshaft facilities
    • rationale: meet demand for eco-friendly marine engines

Samsung Biologics (biopharma CDMO)

  • Role: antibody drug production and cell line processing services (CDMO)
  • Operating profit margin:
    • Q2 (annualized) operating profit margin: 50%
    • +9.1% YoY
  • Growth drivers cited:
    • increased production volume
    • expanding global demand for biopharmaceutical contract manufacturing
  • Capex / geographic expansion:
    • last March: acquired a production facility in Maryland, USA for about 500 million won
    • plans to invest a total of 7.5 trillion won by 2032
    • for construction of “2nd Bio Campus” and factories 5–8

Explicit cautions / risk notes

  • Short-term risk: Heavy capital investment (capex) can cause short-term stock price volatility.
  • Cash flow timing risk: Even with rising revenue/profit, free cash flow can temporarily deteriorate due to capex (example: Alphabet).

Disclosures

  • The subtitle includes no explicit “not financial advice” disclaimer in the provided text (only an investing framing).

Tickers / assets / instruments mentioned

  • No explicit ticker symbols were provided in the subtitles.
  • Companies mentioned (by name):
    • SK Hynix, Samsung Electronics, Sunik Systems, SK Biopharmaceuticals, RFHIC, Konai, SEM CNS, Pharmicel, EO Technics, HD Hyundai Energy Solution
    • Hansun Engineering, HD Hyundai Marine Engine, Celltrion, TLB, TFE, KC Tech, Protec, Jusham
    • Alphabet (Google), Samsung Biologics
  • Asset classes / instruments explicitly referenced:
    • Free cash flow (operating cash flow minus capex)
    • Tangibles / tangible assets
    • Loan assets (noted as increasing for some companies)

Presenter / source

  • Presenter: iInvestment Hansol (as stated in the subtitles)

Original video